Cancer Research KI manages international collaboration agreements signed by Karolinska Institutet with world-leading research centers in the Cancer Research field.
Cancer Core Europe
Karolinska Institutet is one of the seven leading cancer centers that have joined forces to form Cancer Core Europe - a European cancer association carrying out innovative research propelling cancer medicine into a new era.
MD Anderson Cancer Center
Karolinska Institutet signed a collaboration agreement with MD Anderson Cancer Center, Houston Texas, USA in May 2013 and thus became a Sister Institution to MD Anderson. The agreement was renewed in May 2018 after the end of the first successfull 5-year period.
MD Anderson Cancer Center is a top-ranked comprehensive cancer center in the United States. The Sister Institution Agreement with MD Anderson Cancer Center includes KI in the largest network of cancer institutions collaborating with the joint goal to end cancer.
StratCan administers the collaborative efforts with MD Anderson and Sandra Falck serves as Alliance Director and contact point at KI.
The primary joint efforts include:
- Collaborative grants through the SINF (Sister Institution Network Fund) funding mechanism. The KI-MDACC Collaborative grants/ SINF have been announced yearly since 2013 and so far nine projects have received funding (funding of the KI partner by Cancer Research KI).
- Annual GAP conference (Global Academic Programs). The conference is held odd years at MD Anderson in Houston Texas and even years hosted abroad at a Sister Institution. KI/StratCan has participated in the meetings annually since 2013 and Karolinska Institutet & University Hospital were proud hosts of the GAP 2018 conference in Stockholm, May 2018, with 900+ participants from 38 countries.
The GAP 2019 conference will be hosted by MD Anderson Cancer Center in Huston, Texas, April 30th-May 2nd, 2019.
- Joint workshops
- Clinician visits
- Nordic GAP (NGAP)
An annual research symposium began in 1994 between diabetes and metabolism investigators from the Mayo Clinic and the Karolinska Institutet. In 2011, Mayo Clinic and Karolinska Institutet signed an agreement that formalized and encouraged partnerships between the two institutions toward goals in research, education and innovation. Today, Karolinska Institutet and Mayo Clinic support a strong network of collaborations through a joint collaboration platform.
In 2020, the Mayo Clinic and Karolinska Institutet announce a collaborative call within the area of breast cancer.
This newly formed collaboration will begin with an initial phase supporting two demonstration projects in 2020 on the topic of breast cancer, due to already existing links and collaboration between the research entities. The aim of this collaboration is to have a global impact on cancer through research focusing on the diagnosis, prevention, or treatment of breast cancer. A broader programme focusing on additional cancer sites is planned for future calls.
In 2019, Karolinska Institutet and Mayo Clinic celebrate 25 years of fruitful scientific collaboration and exchange.
Collaborative Project Awards provide competitive funds to Mayo Clinic - Karolinska Institutet collaborations to conduct joint research projects.
Collaborative Travel Awards support individuals from Mayo Clinic who travel to Stockholm, Sweden, to work with collaborative partners. In turn, Mayo Clinic welcomes Karolinska Institutet travelers to Mayo Clinic’s three locations.
This year, Yuanyuan Zhang (PhD student at the Department Oncology-Pathology) and Lakshmi Sandhow (PhD student at the Department of Medicine Huddinge) were awarded student travel grants for the 8th Mayo Clinic Symposium on Tumor Microenvironment and Cancer Therapeutics.
StratCan collaborates with The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). Presently, two research projects are jointly funded through this collaboration.